Enhanced Investments - Financial Portal

Published: 2021-01-20 12:19:09 ET

EX-99.1 2 ex_221518.htm EXHIBIT 99.1 ex_221518.htm

Exhibit 99.1

PETMED EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES ITS THIRD FISCAL QUARTER FINANCIAL RESULTS AND ITS QUARTERLY DIVIDEND OF $0.28 PER SHARE

Quarterly Sales Increased 10%

Diluted EPS increased from $0.34 to $0.38 per share

Quarterly Average Order Size increased to $88

Delray Beach, Florida, January 19, 2021, PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the quarter ended December 31, 2020. Net sales for the quarter ended December 31, 2020 were $65.9 million, compared to $59.9 million for the quarter ended December 31, 2019, an increase of 10.0%. Net sales for the nine months ended December 31, 2020 were $237.5 million, compared to $209.8 million for the nine months ended December 31, 2019, an increase of 13.2%. Net income was $7.6 million, or $0.38 diluted per share, for the quarter ended December 31, 2020, compared to net income of $6.8 million, or $0.34 diluted per share, for the quarter ended December 31, 2019, an 11.3% increase to net income. Net income was $23.8 million, or $1.18 diluted per share, for the nine months ended December 31, 2020, compared to net income of $18.8 million, or $0.94 diluted per share, for the nine months ended December 31, 2019, a 26.0% increase to net income. Reorder sales increased 11.9%, to $60.2 million for the quarter ended December 31, 2020, compared to $53.8 million for the same quarter in the prior year. Reorder sales increased 13.6%, to $208.4 million for the nine months ended December 31, 2020, compared to $183.4 million for the same period in the prior year.

Menderes Akdag, CEO and President, commented: “We were pleased with the Company’s performance during the quarter and throughout 2020, where we have seen both double digit top and bottom line growth. Strong reorder sales and increasing gross and operating margins during the quarter contributed to our success. Our reorder growth for the three and nine months ended on December 31, 2020 was likely energized by the increased use of loyalty credits by our customers through our Loyalty Program, which was launched in September 2019, and by our Easy Refill Program. Our average order size increased from $85 to $88 for the quarters ended December 31, 2019 and 2020, respectively. In the beginning of 2021 we unveiled a new logo to commemorate the Company’s 25^th anniversary. The inspiration for this new logo and brand identity came mostly from consumer feedback. We embraced the opportunity to refresh our logo and brand to best represent both pet health and wellness on our new website platform. In the next fiscal year, we will be exploring alternative ways of acquiring new customers and adding value-added services, and we will continue investing in our e-commerce platform and mobile app to optimize our customers’ digital experience.”

The Board of Directors declared a quarterly dividend of $0.28 per share on the Company’s common stock. The dividend will be payable on February 12, 2021, to shareholders of record at the close of business on February 1, 2021. The Company intends to continue to pay regular quarterly dividends; however, the declaration and payment of future dividends is discretionary and will be subject to a determination by the Board of Directors each quarter following its review of the Company’s financial performance.

This morning at 8:30 A.M. Eastern Time, the Company will host a conference call to review the quarter’s financial results. To access the call, which is open to the public, please dial (888) 455-1758 (toll free) or (203) 827-7025. Callers will be required to supply PETMEDS as the passcode. For those unable to participate in the live event, the call will be available for replay from 10:00 A.M. on January 19, 2021 until February 2, 2021 at 11:59 P.M Eastern Time. To access the replay, call (888) 676-2680 (toll free) or (402) 220-6446, and enter passcode 5500.

Founded in 1996, PetMed Express is America’s Most Trusted Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at www.1800petmeds.com.

This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2020. The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K. For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 561-526-4444.

###

Exhibit 99.1 Page 1 of 4

PETMED EXPRESS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except for per share data)

	December 31,		March 31,
	2020		2020
	(Unaudited)
ASSETS

Current assets:
Cash and cash equivalents	$	106,501	$	103,762
Accounts receivable, less allowance for doubtful accounts of $28 and $59, respectively		1,831		3,843
Inventories - finished goods		28,165		17,884
Prepaid expenses and other current assets		4,512		3,529
Total current assets		141,009		129,018

Noncurrent assets:
Property and equipment, net		25,502		25,445
Intangible assets		860		860
Total noncurrent assets		26,362		26,305

Total assets	$	167,371	$	155,323

LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:
Accounts payable	$	21,869	$	19,658
Accrued expenses and other current liabilities		4,429		4,214
Income taxes payable		623		471
Total current liabilities		26,921		24,343

Deferred tax liabilities		1,323		970

Total liabilities		28,244		25,313

Commitments and contingencies

Shareholders' equity:
Preferred stock, $.001 par value, 5,000 shares authorized; 3 convertible shares issued and outstanding with a liquidation preference of $4 per share		9		9
Common stock, $.001 par value, 40,000 shares authorized; 20,271 and 20,166 shares issued and outstanding, respectively		20		20
Additional paid-in capital		6,098		3,804
Retained earnings		133,000		126,177

Total shareholders' equity		139,127		130,010

Total liabilities and shareholders' equity	$	167,371	$	155,323

Exhibit 99.1 Page 2 of 4

PETMED EXPRESS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except for per share amounts) (Unaudited)

	Three Months Ended				Nine Months Ended
	December 31,				December 31,
	2020		2019		2020		2019

Sales	$	65,896	$	59,915	$	237,536	$	209,839
Cost of sales		46,273		42,218		168,110		150,279

Gross profit		19,623		17,697		69,426		59,560

Operating expenses:
General and administrative		6,487		6,040		21,050		18,851
Advertising		3,221		3,163		17,385		16,543
Depreciation		622		562		1,791		1,702
Total operating expenses		10,330		9,765		40,226		37,096

Income from operations		9,293		7,932		29,200		22,464

Other income:
Interest income, net		73		421		229		1,447
Other, net		345		301		938		862
Total other income		418		722		1,167		2,309

Income before provision for income taxes		9,711		8,654		30,367		24,773

Provision for income taxes		2,100		1,814		6,576		5,925

Net income	$	7,611	$	6,840	$	23,791	$	18,848

Net income per common share:
Basic	$	0.38	$	0.34	$	1.19	$	0.94
Diluted	$	0.38	$	0.34	$	1.18	$	0.94

Weighted average number of common shares outstanding:
Basic		20,094		19,984		20,047		20,060
Diluted		20,104		19,994		20,100		20,071

Cash dividends declared per common share	$	0.28	$	0.27	$	0.84	$	0.81

Exhibit 99.1 Page 3 of 4

PETMED EXPRESS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands) (Unaudited)

	Nine Months Ended
	December 31,
	2020			2019
Cash flows from operating activities:
Net income	$	23,791		$	18,848
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation		1,791			1,702
Share based compensation		2,294			2,081
Deferred income taxes		353			(12	)
Bad debt expense		84			102
(Increase) decrease in operating assets and increase (decrease) in liabilities:
Accounts receivable		1,928			388
Inventories - finished goods		(10,281	)		(2,795	)
Prepaid income taxes		-			582
Prepaid expenses and other current assets		(983	)		(1,424	)
Accounts payable		2,211			360
Accrued expenses and other current liabilities		286			851
Income taxes payable		152			895
Net cash provided by operating activities		21,626			21,578

Cash flows from investing activities:
Purchases of property and equipment		(1,848	)		(1,827	)
Net cash used in investing activities		(1,848	)		(1,827	)

Cash flows from financing activities:
Repurchase and retirement of common stock		-			(11,496	)
Dividends paid		(17,039	)		(16,410	)
Net cash used in financing activities		(17,039	)		(27,906	)

Net increase (decrease) in cash and cash equivalents		2,739			(8,155	)
Cash and cash equivalents, at beginning of period		103,762			100,529

Cash and cash equivalents, at end of period	$	106,501		$	92,374

Supplemental disclosure of cash flow information:

Cash paid for income taxes	$	6,356		$	4,460

Property and equipment in current assets	$	-		$	1,344

Dividends payable in accrued expenses	$	174		$	196

Exhibit 99.1 Page 4 of 4

Enhanced Investments, Inc.
329 South Oyster Bay Road #2085
Plainview, NY 11803
team@eninvs.com

Important disclosures

Performance results were prepared by Enhanced Investments, and have not been compiled, reviewed or audited by an independent accountant. Performance estimates are subject to future adjustment and revision. Investors should be aware that a loss of investment is possible. Account holdings are for illustrative purposes only and are not investment recommendations. Additional information, including (i) the calculation methodology; and (ii) a list showing the contribution of each holding to the portfolio’s performance during the time period will be provided upon request.
All statements made via social media sites sponsored or maintained by Enhanced Investments and its affiliates are for informational purposes only and do not constitute a comprehensive description of Enhanced Investments' investment advisory services.
Certain investments are not suitable for all investors. Before investing, consider your investment objectives and applicable fees. The rate of return on investments can vary widely over time, especially for long term investments. Investment losses are possible, including the potential loss of all amounts invested. Information provided by Enhanced Investments is for informational and general educational purposes only and is not investment or financial advice.

Nothing on this website should be considered an offer, solicitation of an offer, or advice to buy or sell securities.
Past performance is no guarantee of future results. Any historical returns, expected returns [or probability projections] are hypothetical in nature and may not reflect actual future performance.
All the strategies assume investments in equity invstrumenta only and are more relevant for "agressive investment profile". Eastern European flagship strategy assumes using up to 20% leverage of total portfolio. GlobalCommodities and US Growth strategy currently assume no leverage.
Results for the Enhanced Investments strategies as compared to the performance of Illustrative Benchmarks is for informational purposes only. Our investment program does not mirror that of the Illustrative Benchmarks and the volatility may be materially different from the volatility of Illustrative Benchmarks. Reference or comparison to an Illustrative Benchmark does not imply that strategies of Enhanced Investments will be constructed in the same way as the Illustrative Benchmark or achieve returns, volatility, or other results similar to those of the Illustrative Benchmark. The S&P 500 is an unmanaged market capitalization-weighted index of 500 common stocks chosen for market size, liquidity, and industry group representation to represent U.S. equity performance.
Performance results were prepared by Enhanced Investments, and have not been compiled, reviewed or audited by an independent accountant. Performance estimates are subject to future adjustment and revision. Investors should be aware that a loss of investment is possible. Account holdings are for illustrative purposes only and are not investment recommendations. Additional information, including (i) the calculation methodology; and (ii) a list showing the contribution of each holding to the portfolio’s performance during the time period will be provided upon request.
All statements made via social media sites sponsored or maintained by Enhanced Investments and its affiliates are for informational purposes only and do not constitute a comprehensive description of Enhanced Investments' investment advisory services.
Certain investments are not suitable for all investors. Before investing, consider your investment objectives and applicable fees. The rate of return on investments can vary widely over time, especially for long term investments. Investment losses are possible, including the potential loss of all amounts invested. Information provided by Enhanced Investments is for informational and general educational purposes only and is not investment or financial advice.